| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Affects phenotype | PMID:35568058 |
| GO:0000050 | Urea cycle | Affects phenotype | PMID:31639282 |
| GO:0000423 | Mitophagy | Increases phenotype | PMID:36794572 |
| GO:0000902 | Cell morphogenesis | Affects phenotype | PMID:35568058 |
| GO:0001837 | Epithelial to mesenchymal transition | Increases phenotype | PMID:22648416; PMID:38488660 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:21544193; PMID:24670797; PMID:36794572; PMID:38488660 |
| GO:0003994 | Aconitate hydratase activity | Decreases phenotype | PMID:24577088 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:31639282 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:34921910 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:31639282 |
| GO:0004396 | Hexokinase activity | Increases phenotype | PMID:24577088 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:31639282 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:25220231; PMID:30389395; PMID:31639282 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:25220231; PMID:30389395; PMID:31639282; PMID:38488660 |
| GO:0005749 | Mitochondrial respiratory chain complex ii, succinate dehydrogenase complex (ubiquinone) | Decreases phenotype | PMID:34921910 |
| GO:0005750 | Mitochondrial respiratory chain complex iii | Decreases phenotype | PMID:34921910 |
| GO:0005776 | Autophagosome | Affects phenotype | PMID:35568058 |
| GO:0006281 | Dna repair | Decreases phenotype | PMID:24711049 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:35568058; PMID:36794572 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:34921910; PMID:36421005 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:31639282 |
| GO:0006790 | Sulfur compound metabolic process | Increases phenotype | PMID:30055191 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:31943712 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:24448832 |
| GO:0007005 | Mitochondrion organization | Affects phenotype | PMID:36794572 |
| GO:0007254 | Jnk cascade | Decreases phenotype | PMID:23536762 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:24577088 |
| GO:0008219 | Cell death | Affects phenotype | PMID:22172632; PMID:22770624; PMID:23828460; PMID:24080332; PMID:26865462; PMID:30724446 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:22770624; PMID:24577088; PMID:25458486; PMID:26044615 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:25446860; PMID:28552779; PMID:30055191 |
| GO:0009636 | Response to toxic substance | Affects phenotype | PMID:24448832 |
| GO:0010045 | Response to nickel cation | Decreases phenotype | PMID:36421005 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Decreases phenotype | PMID:34571076 |
| GO:0010575 | Positive regulation of vascular endothelial growth factor production | Affects phenotype | PMID:8537383 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:26026961; PMID:28472268; PMID:38104653 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25220231; PMID:25560666; PMID:28774209; PMID:30389395; PMID:31639282; PMID:34921910 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:30016632 |
| GO:0030218 | Erythrocyte differentiation | Affects phenotype | PMID:21618677 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:31943712 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:26026961; PMID:30055191 |
| GO:0030964 | Nadh dehydrogenase complex | Decreases phenotype | PMID:34921910 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:35568058 |
| GO:0032088 | Negative regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:23844176 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:31639282 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:26026961 |
| GO:0032631 | Interleukin-27 production | Increases phenotype | PMID:30421605 |
| GO:0033864 | Positive regulation of nad(p)h oxidase activity | Increases phenotype | PMID:25446860 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:36421005 |
| GO:0035065 | Regulation of histone acetylation | Affects phenotype | PMID:38050843 |
| GO:0038066 | P38mapk cascade | Decreases phenotype | PMID:23536762 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:29355601 |
| GO:0042391 | Regulation of membrane potential | Decreases phenotype | PMID:28774209 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:21797922 |
| GO:0042755 | Eating behavior | Affects phenotype | PMID:35568058 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:35568058 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:24448832; PMID:36421005; PMID:38104653 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:21544193 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:31943712; PMID:33774146 |
| GO:0045089 | Positive regulation of innate immune response | Increases phenotype | PMID:26456670 |
| GO:0045277 | Respiratory chain complex iv | Decreases phenotype | PMID:34921910 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:28774209 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:29110037 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:34921910 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:31639282 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:31639282 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:9657286 |
| GO:0046722 | Lactic acid secretion | Increases phenotype | PMID:27452194; PMID:33596451 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Decreases phenotype | PMID:28472268 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:26026961 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:22648416; PMID:38552765 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:34921910 |
| GO:0051899 | Membrane depolarization | Affects phenotype | PMID:28713246 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:34921910; PMID:35568058; PMID:38488660 |
| GO:0071421 | Manganese ion transmembrane transport | Increases phenotype | PMID:8549643 |
| GO:0071481 | Cellular response to x-ray | Increases phenotype | PMID:28472268 |
| GO:0072537 | Fibroblast activation | Increases phenotype | PMID:30055191 |
| GO:0072576 | Liver morphogenesis | Affects phenotype | PMID:21618677 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:24448832; PMID:31943712; PMID:34921910; PMID:35568058; PMID:38552765 |
| GO:0097189 | Apoptotic body | Increases phenotype | PMID:31943712 |
| GO:0098703 | Calcium ion import across plasma membrane | Increases phenotype | PMID:8549643 |
| GO:0140888 | Interferon-mediated signaling pathway | Increases phenotype | PMID:37951547 |
| GO:1900227 | Positive regulation of nlrp3 inflammasome complex assembly | Increases phenotype | PMID:24158569 |
| GO:1901224 | Positive regulation of nik/nf-kappab signaling | Decreases phenotype | PMID:23844176 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:36421005 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Affects phenotype | PMID:24448832 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Affects phenotype | PMID:21797922; PMID:22172632; PMID:22648416; PMID:22770624; PMID:26962057; PMID:28774209; PMID:30389395 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:24158569; PMID:26026961; PMID:30055191 |
| GO:1904827 | Negative regulation of hydrogen sulfide biosynthetic process | Increases phenotype | PMID:30055191 |
| GO:1905168 | Positive regulation of double-strand break repair via homologous recombination | Decreases phenotype | PMID:28472268 |
| GO:2000147 | Positive regulation of cell motility | Decreases phenotype | PMID:23844176 |
| GO:2000304 | Positive regulation of ceramide biosynthetic process | Affects phenotype | PMID:24448832 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:28552779 |
| GO:2001034 | Positive regulation of double-strand break repair via nonhomologous end joining | Increases phenotype | PMID:28472268 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:31639282 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.